2014 Q4 Form 10-Q Financial Statement

#000088250814000015 Filed on November 04, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $5.720M $4.124M $9.066M
YoY Change -35.44% -54.51% 147.91%
Cost Of Revenue $3.510M $2.361M $6.037M
YoY Change -42.46% -60.89% 215.08%
Gross Profit $2.210M $1.763M $3.029M
YoY Change -20.22% -41.8% 73.98%
Gross Profit Margin 38.64% 42.75% 33.41%
Selling, General & Admin $2.770M $2.579M $3.207M
YoY Change -17.31% -19.58% 20.65%
% of Gross Profit 125.34% 146.28% 105.88%
Research & Development $3.430M $3.057M $2.052M
YoY Change 38.87% 48.98% 10.03%
% of Gross Profit 155.2% 173.4% 67.75%
Depreciation & Amortization $380.0K $400.0K $320.0K
YoY Change -2.56% 25.0% 6.67%
% of Gross Profit 17.19% 22.69% 10.56%
Operating Expenses $6.200M $5.636M $5.227M
YoY Change 6.53% 7.82% 15.56%
Operating Profit -$3.990M -$3.873M -$2.198M
YoY Change 30.82% 76.21% -20.99%
Interest Expense -$20.00K $34.00K $8.000K
YoY Change 0.0% 325.0% -33.33%
% of Operating Profit
Other Income/Expense, Net -$50.00K -$17.00K -$74.00K
YoY Change 66.67% -77.03% -511.11%
Pretax Income -$4.060M -$3.924M -$2.280M
YoY Change 30.97% 72.11% -17.87%
Income Tax $90.00K $6.000K -$18.00K
% Of Pretax Income
Net Earnings -$4.140M -$3.930M -$2.262M
YoY Change 29.78% 73.74% -19.16%
Net Earnings / Revenue -72.38% -95.3% -24.95%
Basic Earnings Per Share -$0.07 -$0.05
Diluted Earnings Per Share -$1.035M -$0.07 -$0.05
COMMON SHARES
Basic Shares Outstanding 55.86M shares 55.81M shares 44.76M shares
Diluted Shares Outstanding 55.81M shares 44.76M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.10M $31.20M $14.90M
YoY Change -19.52% 109.4% -45.42%
Cash & Equivalents $30.05M $31.16M $14.87M
Short-Term Investments $0.00
Other Short-Term Assets $104.0K $84.00K $83.00K
YoY Change -75.64% 1.2% 137.14%
Inventory $4.952M $6.878M $2.851M
Prepaid Expenses $1.042M $880.0K $589.0K
Receivables $1.552M $1.747M $4.995M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $37.70M $40.75M $23.39M
YoY Change -18.18% 74.22% -22.37%
LONG-TERM ASSETS
Property, Plant & Equipment $3.217M $2.889M $3.007M
YoY Change 13.27% -3.92% 3.16%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $222.0K $228.0K $238.0K
YoY Change 5.21% -4.2% 17.82%
Total Long-Term Assets $3.439M $3.117M $3.245M
YoY Change 12.72% -3.94% 4.11%
TOTAL ASSETS
Total Short-Term Assets $37.70M $40.75M $23.39M
Total Long-Term Assets $3.439M $3.117M $3.245M
Total Assets $41.14M $43.87M $26.63M
YoY Change -16.26% 64.7% -19.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.500M $1.700M $3.100M
YoY Change -30.56% -45.16% 47.62%
Accrued Expenses $1.574M $1.839M $2.606M
YoY Change -55.27% -29.43% 44.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $200.0K $200.0K $1.200M
YoY Change -83.33% -83.33% 300.0%
Total Short-Term Liabilities $4.305M $3.786M $6.887M
YoY Change -47.97% -45.03% 83.36%
LONG-TERM LIABILITIES
Long-Term Debt $1.200M $1.200M $0.00
YoY Change 1100.0% -100.0%
Other Long-Term Liabilities $76.00K $64.00K $114.0K
YoY Change -37.19% -43.86% -22.45%
Total Long-Term Liabilities $76.00K $64.00K $114.0K
YoY Change -37.19% -43.86% -22.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.305M $3.786M $6.887M
Total Long-Term Liabilities $76.00K $64.00K $114.0K
Total Liabilities $5.572M $5.075M $7.001M
YoY Change -34.66% -27.51% 66.41%
SHAREHOLDERS EQUITY
Retained Earnings -$202.9M -$198.8M -$185.5M
YoY Change 6.89% 7.16% 6.0%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $35.57M $38.79M $19.63M
YoY Change
Total Liabilities & Shareholders Equity $41.14M $43.87M $26.63M
YoY Change -16.26% 64.7% -19.89%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$4.140M -$3.930M -$2.262M
YoY Change 29.78% 73.74% -19.16%
Depreciation, Depletion And Amortization $380.0K $400.0K $320.0K
YoY Change -2.56% 25.0% 6.67%
Cash From Operating Activities -$960.0K -$3.140M -$2.660M
YoY Change -14.29% 18.05% 19.82%
INVESTING ACTIVITIES
Capital Expenditures -$520.0K -$10.00K -$1.130M
YoY Change 940.0% -99.12% 465.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$520.0K $0.00 -$1.120M
YoY Change 940.0% -100.0% 460.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 370.0K -20.00K 900.0K
YoY Change -98.44% -102.22% -92.54%
NET CHANGE
Cash From Operating Activities -960.0K -3.140M -2.660M
Cash From Investing Activities -520.0K 0.000 -1.120M
Cash From Financing Activities 370.0K -20.00K 900.0K
Net Change In Cash -1.110M -3.160M -2.880M
YoY Change -104.93% 9.72% -129.88%
FREE CASH FLOW
Cash From Operating Activities -$960.0K -$3.140M -$2.660M
Capital Expenditures -$520.0K -$10.00K -$1.130M
Free Cash Flow -$440.0K -$3.130M -$1.530M
YoY Change -58.88% 104.58% -24.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
3578000 USD
CY2014Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1724000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3261000 USD
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1747000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3519000 USD
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1839000 USD
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15682000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15153000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
230373000 USD
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
237500000 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
452000 USD
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
330000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1750000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1067000 USD
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7300000 shares
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6600000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6600000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7300000 shares
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
3000 USD
CY2013Q4 us-gaap Assets
Assets
49126000 USD
CY2014Q3 us-gaap Assets
Assets
43865000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
46075000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
40748000 USD
CY2013Q4 us-gaap Capital Lease Obligations
CapitalLeaseObligations
310000 USD
CY2014Q3 us-gaap Capital Lease Obligations
CapitalLeaseObligations
448000 USD
CY2014Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
223000 USD
CY2013Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
177000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
194000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
448000 USD
CY2014Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
225000 USD
CY2013Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
133000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31159000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37406000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14871000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22578000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6247000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7707000 USD
CY2012Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2304900 shares
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53788000 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55859000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53788000 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55859000 shares
CY2013Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
54000 USD
CY2014Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
56000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9076000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3930000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2262000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13287000 USD
CY2014Q3 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
1448000 USD
CY2013Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
1310000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8937000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11210000 USD
CY2014Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2361000 USD
CY2013Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6037000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
952000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1129000 USD
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1452000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2821000 USD
us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
4300000 USD
us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
108000 USD
CY2014Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
37000 USD
CY2014Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1900000 USD
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1400000 USD
CY2014Q3 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
71000 USD
us-gaap Fiscal Period
FiscalPeriod
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:37px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">QuickLogic's fiscal year ends on the Sunday closest to December&#160;31 and the fiscal quarters each end on the Sunday closest to the end of each calendar quarter. QuickLogic's </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">third</font><font style="font-family:inherit;font-size:10pt;"> fiscal quarter for </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2014</font><font style="font-family:inherit;font-size:10pt;"> and for </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2013</font><font style="font-family:inherit;font-size:10pt;"> ended on Sunday, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">September&#160;28, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">September&#160;29, 2013</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div>
CY2014Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
181000 USD
CY2013Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-27000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
3029000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
1763000 USD
us-gaap Gross Profit
GrossProfit
8837000 USD
us-gaap Gross Profit
GrossProfit
5999000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2280000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8955000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3924000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8718000 USD
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
4000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-18000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-18000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
369000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
862000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-2106000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1514000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3733000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-635000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1396000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2838000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
202000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-291000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-350000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-57000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-27000 USD
us-gaap Interest Expense
InterestExpense
37000 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
34000 USD
us-gaap Interest Expense
InterestExpense
67000 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
8000 USD
CY2014Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5745000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2774000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
4136000 USD
CY2014Q3 us-gaap Inventory Net
InventoryNet
6878000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19000 USD
CY2014Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
0 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1343000 USD
CY2014Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1133000 USD
us-gaap Inventory Write Down
InventoryWriteDown
379000 USD
us-gaap Inventory Write Down
InventoryWriteDown
96000 USD
CY2014Q3 us-gaap Liabilities
Liabilities
5075000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
8528000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49126000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43865000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3786000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8274000 USD
CY2014Q3 us-gaap Line Of Credit
LineOfCredit
1000000 USD
CY2013Q4 us-gaap Line Of Credit
LineOfCredit
1000000 USD
CY2014Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2013Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1000000 USD
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1225000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
133000 USD
CY2014Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
223000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1177000 USD
CY2014Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
1000000 USD
CY2013Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4066000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1176000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-942000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-523000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9790000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7941000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-2262000 USD
us-gaap Net Income Loss
NetIncomeLoss
-8937000 USD
us-gaap Net Income Loss
NetIncomeLoss
-9087000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-3930000 USD
CY2014Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2013Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
us-gaap Operating Expenses
OperatingExpenses
14731000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
5227000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
5636000 USD
us-gaap Operating Expenses
OperatingExpenses
17646000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2198000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8732000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3873000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8809000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3578000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
799000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
781000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
847000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
925000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
226000 USD
CY2013Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
234000 USD
CY2014Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
239000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
726000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
710000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
698000 USD
CY2014Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
387000 USD
CY2013Q4 us-gaap Other Assets Current
OtherAssetsCurrent
427000 USD
CY2014Q3 us-gaap Other Assets Current
OtherAssetsCurrent
84000 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
228000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
211000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
11000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
0 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
121000 USD
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
64000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-79000 USD
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-74000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-130000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
70000 USD
CY2012Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
929000 USD
CY2013Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2200000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
525000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1207000 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2013Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1272000 USD
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
964000 USD
CY2014Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
880000 USD
CY2013Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
845000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
428000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4334000 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 USD
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1000000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
265000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2000 USD
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18571000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17993000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2840000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2889000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-20000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5902000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2052000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8754000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3057000 USD
CY2013Q3 us-gaap Restructuring Costs
RestructuringCosts
-32000 USD
CY2014Q3 us-gaap Restructuring Costs
RestructuringCosts
0 USD
us-gaap Restructuring Costs
RestructuringCosts
0 USD
us-gaap Restructuring Costs
RestructuringCosts
181000 USD
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
268000 USD
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
182000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-198766000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189829000 USD
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
9066000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
22124000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
17209000 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
4124000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8648000 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3207000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8892000 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2579000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1750000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1067000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
24000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
416000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.47
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
317000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
225000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.36
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.17
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
300000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
4.76
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4461000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.55
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3700000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
46000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
154000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
208000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.39
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.30
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3237000 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5609000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.55
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7242000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.62
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.66
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
3199000 USD
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5404000 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.64
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.56
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.84
CY2013Q4 us-gaap Share Price
SharePrice
2.90
CY2014Q3 us-gaap Share Price
SharePrice
3.03
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2992000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y5M1D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y3M15D
CY2012Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5122000 shares
CY2013Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
8740000 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1687000 shares
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
40598000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
38790000 USD
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
79000 USD
CY2014Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
47000 USD
CY2014Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
21000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Uses of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:37px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities and the reported amounts of revenue and expenses during the period. Actual results could differ from those estimates, particularly in relation to revenue recognition, the allowance for doubtful accounts, sales returns, valuation of investments, valuation of long-lived assets, valuation of inventories including identification of excess quantities, market value and obsolescence, measurement of stock-based compensation awards, accounting for income taxes and estimating accrued liabilities.</font></div></div>
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55812000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55208000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44640000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44761000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55208000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55812000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44761000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44640000 shares
CY2013Q4 quik Proceeds From Issuance Of Common Stock And Warrants Net Of Stock Issuance Costs
ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfStockIssuanceCosts
23100000 USD
CY2012Q2 quik Proceeds From Issuance Of Common Stock And Warrants Net Of Stock Issuance Costs
ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfStockIssuanceCosts
11900000 USD
quik Purchase Of Equipment Included In Accounts Payable
PurchaseOfEquipmentIncludedInAccountsPayable
123000 USD
quik Purchase Of Equipment Included In Accounts Payable
PurchaseOfEquipmentIncludedInAccountsPayable
33000 USD
CY2013Q3 quik Shelf Registration Maximum Offering
ShelfRegistrationMaximumOffering
40000000.0 USD
quik Tax Effect From Reclassificationof Unrealized Gainson Investmentsin Available
TaxEffectFromReclassificationofUnrealizedGainsonInvestmentsinAvailable
273000 USD
quik Tax Effect From Reclassificationof Unrealized Gainson Investmentsin Available
TaxEffectFromReclassificationofUnrealizedGainsonInvestmentsinAvailable
0 USD
CY2014Q3 quik Unrecognized Tax Benefits Expiringfrom Lapseof Applicable Statuteof Limitationin Next Twelve Months
UnrecognizedTaxBenefitsExpiringfromLapseofApplicableStatuteofLimitationinNextTwelveMonths
16000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-28
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Period End Date
DocumentPeriodEndDate
2014-09-28
dei Document Type
DocumentType
10-Q
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000882508
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55859141 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
QUICKLOGIC CORPORATION

Files In Submission

Name View Source Status
0000882508-14-000015-index-headers.html Edgar Link pending
0000882508-14-000015-index.html Edgar Link pending
0000882508-14-000015.txt Edgar Link pending
0000882508-14-000015-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
firstamendmenttothirdloana.htm Edgar Link pending
quik-20140928.xml Edgar Link completed
quik-20140928.xsd Edgar Link pending
quik-20140928_cal.xml Edgar Link unprocessable
quik-20140928_def.xml Edgar Link unprocessable
quik-20140928_lab.xml Edgar Link unprocessable
quik-20140928_pre.xml Edgar Link unprocessable
quik_20140928x10q.htm Edgar Link pending
quik_20140928x10qex311.htm Edgar Link pending
quik_20140928x10qex312.htm Edgar Link pending
quik_20140928x10qex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending